Literature DB >> 14698495

Hypodermoclysis (subcutaneous infusion) effective mode of treatment of dehydration in long-term care patients.

Zeev Arinzon1, Jacob Feldman, Zeev Fidelman, Reuven Gepstein, Yitshal N Berner.   

Abstract

Dehydration is associated with morbidity and mortality in frail elderly patients. Intravenous fluid administration in these patients is sometimes hard, especially in agitated patients. The purpose of this study was to review of 57 long-termed care patients received hypodermoclysis infusion on 118 different occasions during the 9 months. Data collection included: demographic data, functional and mental status, indication hypodermoclysis, duration of the infusion, type of solution, laboratory data, adverse effects, and outcome. The main reasons for initiation of the hypodermoclysis were either dehydration (64%) or febrile illness (21%). The average duration of infusions was 15.9 days and average daily volume was 1161 ml per day. After hydration by hypodermoclysis, in 77% of the patients, clinical improvement occurred manifested as general improvement (88%), cognitive status improvement (84%), and improved oral intake (81%). During the course of the study, failure of the treatment was observed in 12% of the patients, mortality of 11% was observed. Nobody developed signs of fluid overload. Local complications were reported in 12% of patients: local swelling (6/57), complain of local pain at site (3/57) and local inflammation (2/57). Hypodermoclysis is a safe, effective and suitable alternative to intravenous re-hydration in long-term care patients.

Entities:  

Mesh:

Year:  2004        PMID: 14698495     DOI: 10.1016/j.archger.2003.09.003

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  4 in total

1.  [Subcutaneous infusions for geriatric patients: rediscovery of an "old" technique].

Authors:  A H Leischker
Journal:  Z Gerontol Geriatr       Date:  2012-10       Impact factor: 1.281

2.  Comparison of the tolerability of recombinant human hyaluronidase + normal saline and recombinant human hyaluronidase + lactated ringer's solution administered subcutaneously: A phase IV, double-blind, randomized pilot study in healthy volunteers.

Authors:  Samuel S Dychter; David Ebel; Tonya R Mead; Richard C Yocum
Journal:  Curr Ther Res Clin Exp       Date:  2009-12

Review 3.  Hypodermoclysis: a literature review to assist in clinical practice.

Authors:  Vanessa Galuppo Bruno
Journal:  Einstein (Sao Paulo)       Date:  2015-03-24

4. 

Authors:  Manuel Castro Barrio; Mercedes Portillo Ruiz; Nuria Martínez Gordillo
Journal:  FMC       Date:  2013-10-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.